jeudi 18 juin 2015

Onco Actu du 18 juin 2015

1. Biologie

Organ Models on Chips [In the Pipeline]

3.1 Tabac

To Cut Teen Smoking, Raise Tobacco Sales Age [NY Times]

4. Dépistage, diagnostic et pronostic

Beating Advanced Cancers: New Epigenomic Block for Advanced Cancer Progression [Mayo Clinic]

5. Traitements

Could avocados hold the key to treating leukaemia? [NHS Choices]

5.12 Immunothérapies

Biotech’s Coming Cancer Cure [MIT Technology Review]

5.2 Pharma

Seattle Genetics Announces Multiple ADCETRIS® (Brentuximab Vedotin) Data Presentations at the International Conference on Malignant Lymphoma [Seattle Genetics]

Servier bags EU rights to colorectal cancer drug in $130M deal [FierceBiotech]

ImmunoGen's IMGN529 for B-Cell Malignancies Demonstrates Synergistic Activity with Rituximab in Preclinical Models of Non-Hodgkin Lymphoma [ImmunoGen]

GSK to create independent research institute with goal of radically changing and improving medicines development [GSK]

5.2.1 Pharma - Partenariats

€323m cancer deal for Irish Almac [European Biotechnology News]

Lilly and Dana-Farber Cancer Institute Announce Research Collaboration [Lilly]

Eli Lilly and Company Enters Into Strategic Partnership with Sarah Cannon Research Institute to Develop Investigational Oncology Therapy [Lilly]

6.10 Politiques

Cancer Experts Discuss the Latest in Precision Medicine [CANCER RESEARCH Catalyst]

6.6 Publications

Science, Now Under Scrutiny Itself [NYTimes]

Widespread Data Duplication [The Scientist]

The Problem(s) With Credit for Peer Review [The Scholarly Kitchen]

6.7 DMP, Big Data & applis

NHS England unveils digital roadmap [Pharmafile]

6.8 Communication

Everybody's talking at me, on health on Twitter [HealthNewsReview]